Now that 2020 is in the rearview mirror (*collective sigh of relief*), we wanted to share our perspective on notable decisions and trends from this past year at the National Advertising Division and the advertising self-regulation industry’s appellate body, the National Advertising Review Board.

2020 was another busy year at NAD, with more than 100 closed cases. Over 20 of those were monitoring cases NAD initiated. In its monitoring role, NAD unsurprisingly focused on COVID-related claims, including disinfecting and immune support claims that reasonably implied some form of protection against infection from or symptoms caused by the coronavirus. NAD also initiated monitoring cases in other areas, including dietary supplements and household products.